Share on StockTwits
 

Equities research analysts at Bank of America Corp. raised their target price on shares of Illumina (NASDAQ:ILMN) from $125.00 to $165.00 in a research note issued to investors on Friday, AnalystRatingsNetwork.com reports. Bank of America Corp.’s price target would suggest a potential upside of 31.73% from the company’s current price.

Shares of Illumina (NASDAQ:ILMN) traded up 7.80% on Friday, hitting $135.035. The stock had a trading volume of 3,702,377 shares. Illumina has a 1-year low of $48.00 and a 1-year high of $127.00. The stock’s 50-day moving average is $107. and its 200-day moving average is $88.. The company has a market cap of $17.068 billion and a price-to-earnings ratio of 149.47.

Illumina (NASDAQ:ILMN) last released its earnings data on Monday, October 21st. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.05. The company had revenue of $357.00 million for the quarter, compared to the consensus estimate of $343.42 million. During the same quarter in the previous year, the company posted $0.41 earnings per share. The company’s revenue for the quarter was up 24.9% on a year-over-year basis. On average, analysts predict that Illumina will post $1.78 earnings per share for the current fiscal year.

In other Illumina news, CEO Jay Flatley unloaded 30,000 shares of the company’s stock in a transaction dated Thursday, January 9th. The shares were sold at an average price of $114.77, for a total value of $3,443,100.00. Following the completion of the sale, the chief executive officer now directly owns 399,509 shares in the company, valued at approximately $45,851,648. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

ILMN has been the subject of a number of other recent research reports. Analysts at Robert W. Baird raised their price target on shares of Illumina from $87.00 to $137.00 in a research note to investors on Friday. Separately, analysts at JPMorgan Chase & Co. raised their price target on shares of Illumina from $120.00 to $190.00 in a research note to investors on Friday. Finally, analysts at Merrill Lynch raised their price target on shares of Illumina from $20.00 to $165.00 in a research note to investors on Friday. They now have a “buy” rating on the stock. Seven research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $113.11.

Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.